197 related articles for article (PubMed ID: 10683383)
21. The interaction of taxol and vinblastine with radiation induction of p53 and p21 WAF1/CIP1.
Tishler RB; Lamppu DM
Br J Cancer Suppl; 1996 Jul; 27():S82-5. PubMed ID: 8763853
[TBL] [Abstract][Full Text] [Related]
22. p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation.
Broude EV; Swift ME; Vivo C; Chang BD; Davis BM; Kalurupalle S; Blagosklonny MV; Roninson IB
Oncogene; 2007 Oct; 26(48):6954-8. PubMed ID: 17486059
[TBL] [Abstract][Full Text] [Related]
23. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells.
Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M
Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911
[TBL] [Abstract][Full Text] [Related]
24. Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner.
Stewart ZA; Tang LJ; Pietenpol JA
Oncogene; 2001 Jan; 20(1):113-24. PubMed ID: 11244509
[TBL] [Abstract][Full Text] [Related]
25. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
[TBL] [Abstract][Full Text] [Related]
26. Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancers.
Masuda A; Maeno K; Nakagawa T; Saito H; Takahashi T
Am J Pathol; 2003 Sep; 163(3):1109-16. PubMed ID: 12937152
[TBL] [Abstract][Full Text] [Related]
27. Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.
Verheul HM; Qian DZ; Carducci MA; Pili R
Cancer Chemother Pharmacol; 2007 Aug; 60(3):329-39. PubMed ID: 17256134
[TBL] [Abstract][Full Text] [Related]
28. Characterization of adriamycin-induced G2 arrest and its abrogation by caffeine in FL-amnion cells with or without p53.
Minemoto Y; Gannon J; Masutani M; Nakagama H; Sasagawa T; Inoue M; Masamune Y; Yamashita K
Exp Cell Res; 2001 Jan; 262(1):37-48. PubMed ID: 11120603
[TBL] [Abstract][Full Text] [Related]
29. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S
Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990
[TBL] [Abstract][Full Text] [Related]
30. Induced p53 expression in lung cancer cell line promotes cell senescence and differentially modifies the cytotoxicity of anti-cancer drugs.
Wang Y; Blandino G; Oren M; Givol D
Oncogene; 1998 Oct; 17(15):1923-30. PubMed ID: 9788435
[TBL] [Abstract][Full Text] [Related]
31. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.
Blajeski AL; Phan VA; Kottke TJ; Kaufmann SH
J Clin Invest; 2002 Jul; 110(1):91-9. PubMed ID: 12093892
[TBL] [Abstract][Full Text] [Related]
32. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S; Lowe M; Herliczek TW; Keyomarsi K
Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
[TBL] [Abstract][Full Text] [Related]
33. Cyclin G2 is a centrosome-associated nucleocytoplasmic shuttling protein that influences microtubule stability and induces a p53-dependent cell cycle arrest.
Arachchige Don AS; Dallapiazza RF; Bennin DA; Brake T; Cowan CE; Horne MC
Exp Cell Res; 2006 Dec; 312(20):4181-204. PubMed ID: 17123511
[TBL] [Abstract][Full Text] [Related]
34. The investigational new drug XK469 induces G(2)-M cell cycle arrest by p53-dependent and -independent pathways.
Ding Z; Parchment RE; LoRusso PM; Zhou JY; Li J; Lawrence TS; Sun Y; Wu GS
Clin Cancer Res; 2001 Nov; 7(11):3336-42. PubMed ID: 11705845
[TBL] [Abstract][Full Text] [Related]
35. UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1.
Yu Q; La Rose J; Zhang H; Takemura H; Kohn KW; Pommier Y
Cancer Res; 2002 Oct; 62(20):5743-8. PubMed ID: 12384533
[TBL] [Abstract][Full Text] [Related]
36. Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells.
Lüpertz R; Wätjen W; Kahl R; Chovolou Y
Toxicology; 2010 May; 271(3):115-21. PubMed ID: 20346999
[TBL] [Abstract][Full Text] [Related]
37. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
38. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
Galmarini CM; Falette N; Tabone E; Levrat C; Britten R; Voorzanger-Rousselot N; Roesch-Gateau O; Vanier-Viornery A; Puisieux A; Dumontet C
Br J Cancer; 2001 Sep; 85(6):902-8. PubMed ID: 11556844
[TBL] [Abstract][Full Text] [Related]
39. Suramin increases p53 protein levels but does not activate the p53-dependent G1 checkpoint.
Howard SP; Park SJ; Hughes-Davies L; Coleman CN; Price BD
Clin Cancer Res; 1996 Feb; 2(2):269-76. PubMed ID: 9816169
[TBL] [Abstract][Full Text] [Related]
40. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
